This Investment Digest is an update for its previous iteration. It summarizes key players and observations in the private equity and venture capital ecosystem, focusing on pharmaceutical Artificial Intelligence (AI).

​

Here we present the information on key industry trends, 470 promising AI-in-Pharma startups, and 50 leading biotech investors in this sector, outlining major investment rounds and relevant R&D partnerships illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire the most successful AI-vendors.